Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s Wockhardt Selling Two Foreign Subsidiaries To Raise Funds

This article was originally published in PharmAsia News

Executive Summary

Wockhardt of India is putting Negma Laboratories, a France-based subsidiary up for sale, one of at least two Wockhardt plants to be disposed of. The sales are part of a plan to raise funds to repay investors, according to an equity fund executive. Wockhardt also plans to sell its Irish subsidiary. The fund executive said the sales have become necessary because the company has not been able to work out deals with potential investors. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts